AP3000A - Slow release pharmaceutical composition made of microparticles - Google Patents

Slow release pharmaceutical composition made of microparticles

Info

Publication number
AP3000A
AP3000A AP2009005088A AP2009005088A AP3000A AP 3000 A AP3000 A AP 3000A AP 2009005088 A AP2009005088 A AP 2009005088A AP 2009005088 A AP2009005088 A AP 2009005088A AP 3000 A AP3000 A AP 3000A
Authority
AP
ARIPO
Prior art keywords
microparticles
pharmaceutical composition
slow release
release pharmaceutical
composition made
Prior art date
Application number
AP2009005088A
Other languages
English (en)
Other versions
AP2009005088A0 (en
Inventor
Bertrand Ducrey
Patrick Garrouste
Catherine Curdy
Original Assignee
Debiopharm Res & Mfg Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40032512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3000(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debiopharm Res & Mfg Sa filed Critical Debiopharm Res & Mfg Sa
Publication of AP2009005088A0 publication Critical patent/AP2009005088A0/en
Application granted granted Critical
Publication of AP3000A publication Critical patent/AP3000A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2009005088A 2007-06-06 2008-06-06 Slow release pharmaceutical composition made of microparticles AP3000A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109767 2007-06-06
IB2007054372 2007-10-27

Publications (2)

Publication Number Publication Date
AP2009005088A0 AP2009005088A0 (en) 2009-12-31
AP3000A true AP3000A (en) 2014-10-31

Family

ID=40032512

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009005088A AP3000A (en) 2007-06-06 2008-06-06 Slow release pharmaceutical composition made of microparticles

Country Status (32)

Country Link
US (3) US10166181B2 (fr)
EP (3) EP2164467B1 (fr)
JP (1) JP5419169B2 (fr)
KR (1) KR101631475B1 (fr)
CN (1) CN101677959B (fr)
AP (1) AP3000A (fr)
AU (1) AU2008259411B2 (fr)
BR (1) BRPI0812250B8 (fr)
CA (1) CA2688478C (fr)
CO (1) CO6251234A2 (fr)
CY (2) CY1118434T1 (fr)
DK (2) DK2164467T3 (fr)
EA (1) EA019284B1 (fr)
ES (2) ES2611020T3 (fr)
HK (1) HK1141737A1 (fr)
HR (2) HRP20161785T1 (fr)
HU (2) HUE040391T2 (fr)
IL (1) IL202501A (fr)
LT (2) LT2164467T (fr)
MA (1) MA31422B1 (fr)
ME (1) ME00959B (fr)
MX (1) MX2009012856A (fr)
MY (1) MY150450A (fr)
NZ (1) NZ582423A (fr)
PL (2) PL2500014T3 (fr)
PT (2) PT2164467T (fr)
RS (2) RS58248B1 (fr)
SI (2) SI2164467T1 (fr)
TN (1) TN2009000476A1 (fr)
UA (1) UA99830C2 (fr)
WO (1) WO2008149320A2 (fr)
ZA (1) ZA200907940B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2164467T (lt) 2007-06-06 2017-01-25 Debiopharm Research & Manufacturing Sa Lėto atpalaidavimo mikrodalelių farmacinė kompozicija
PT105270B (pt) 2010-08-26 2012-05-31 Domino Ind Ceramicas S A Camada de sílica com libertação lenta de fragrância, telha cerâmica e respectivo processo de produção
CN105267153B (zh) * 2015-11-27 2018-05-11 上海苏豪逸明制药有限公司 一种曲普瑞林缓释微粒及其制备方法
CN105797134B (zh) * 2016-03-29 2019-06-14 浙江圣兆药物科技股份有限公司 一种难溶亮丙瑞林缓释制剂
WO2018083633A1 (fr) 2016-11-02 2018-05-11 Debiopharm International, S.A. Procédés d'amélioration d'une thérapie immunoconjuguée anti-cd37
KR102402639B1 (ko) 2017-11-24 2022-05-26 삼성전자주식회사 전자 장치 및 그의 통신 방법
CN111000798B (zh) * 2019-12-26 2021-11-23 四川恒博生物科技有限公司 一种采用原位凝胶技术的犬用非手术去势注射液
IT202000017191A1 (it) 2020-07-15 2022-01-15 Xbrane Biopharma Ab Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134122A (en) * 1989-07-28 1992-07-28 Debiopharm S.A. Method for preparing a pharmaceutical composition in the form of microparticles
GB2257909A (en) * 1991-07-22 1993-01-27 Debio Rech Pharma Sa Preparation of controlled release peptide compositions
US5192741A (en) * 1987-09-21 1993-03-09 Debiopharm S.A. Sustained and controlled release of water insoluble polypeptides
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
US5540937A (en) * 1992-07-27 1996-07-30 Rhone Merieux Process for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and formulations obtained
US20020013273A1 (en) * 1997-11-07 2002-01-31 Bret Shirley Method for producing sustained-release formulations
US20040170665A1 (en) * 2000-06-02 2004-09-02 Allergan, Inc. Intravitreal botulinum toxin implant
WO2004096259A1 (fr) * 2003-04-30 2004-11-11 Debiopharm S.A. Methodes et compositions mettant en oeuvre la gonadoliberine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE61935T1 (de) 1985-02-07 1991-04-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
MY107937A (en) 1990-02-13 1996-06-29 Takeda Chemical Industries Ltd Prolonged release microcapsules.
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
DK0724431T3 (da) * 1993-10-22 2003-01-06 Genentech Inc Fremgangsmåder og sammensætninger til mikroindkapsling af adjuvanser
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
TW577759B (en) 1997-04-18 2004-03-01 Ipsen Pharma Biotech Sustained release compositions in the form of microcapsules or implants and the process for their preparation
TWI284048B (en) * 2000-01-27 2007-07-21 Zentaris Ag Compressed microparticles for dry injection
MXPA04003433A (es) 2001-10-10 2004-08-11 Pf Medicament Microesferas biodegradables de liberacion prolongada y metodo para preparar las mismas.
KR100466637B1 (ko) * 2003-06-26 2005-01-13 주식회사 펩트론 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
KR20130024987A (ko) 2005-12-22 2013-03-08 노파르티스 아게 옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제
LT2164467T (lt) 2007-06-06 2017-01-25 Debiopharm Research & Manufacturing Sa Lėto atpalaidavimo mikrodalelių farmacinė kompozicija

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192741A (en) * 1987-09-21 1993-03-09 Debiopharm S.A. Sustained and controlled release of water insoluble polypeptides
US5134122A (en) * 1989-07-28 1992-07-28 Debiopharm S.A. Method for preparing a pharmaceutical composition in the form of microparticles
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
GB2257909A (en) * 1991-07-22 1993-01-27 Debio Rech Pharma Sa Preparation of controlled release peptide compositions
US5540937A (en) * 1992-07-27 1996-07-30 Rhone Merieux Process for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and formulations obtained
US20020013273A1 (en) * 1997-11-07 2002-01-31 Bret Shirley Method for producing sustained-release formulations
US20040170665A1 (en) * 2000-06-02 2004-09-02 Allergan, Inc. Intravitreal botulinum toxin implant
WO2004096259A1 (fr) * 2003-04-30 2004-11-11 Debiopharm S.A. Methodes et compositions mettant en oeuvre la gonadoliberine

Also Published As

Publication number Publication date
EA200971132A1 (ru) 2010-04-30
EP3431077A1 (fr) 2019-01-23
RS55591B1 (sr) 2017-06-30
JP2010529106A (ja) 2010-08-26
PL2500014T3 (pl) 2019-04-30
CY1120891T1 (el) 2019-12-11
MX2009012856A (es) 2009-12-15
US20110052717A1 (en) 2011-03-03
US20230082575A1 (en) 2023-03-16
AU2008259411A1 (en) 2008-12-11
EA019284B1 (ru) 2014-02-28
BRPI0812250B8 (pt) 2021-05-25
DK2164467T3 (en) 2017-01-30
MA31422B1 (fr) 2010-06-01
BRPI0812250A2 (pt) 2014-12-23
ZA200907940B (en) 2010-08-25
CA2688478A1 (fr) 2008-12-11
CN101677959A (zh) 2010-03-24
PT2500014T (pt) 2018-11-21
PT2164467T (pt) 2017-01-13
TN2009000476A1 (en) 2011-03-31
HRP20181854T1 (hr) 2019-02-08
HUE040391T2 (hu) 2019-03-28
BRPI0812250B1 (pt) 2020-03-03
HK1141737A1 (en) 2010-11-19
SI2500014T1 (sl) 2019-02-28
AU2008259411B2 (en) 2013-10-17
KR101631475B1 (ko) 2016-06-20
UA99830C2 (uk) 2012-10-10
IL202501A (en) 2015-11-30
EP2164467B1 (fr) 2016-12-14
CN101677959B (zh) 2014-02-26
JP5419169B2 (ja) 2014-02-19
WO2008149320A2 (fr) 2008-12-11
CA2688478C (fr) 2015-10-27
AP2009005088A0 (en) 2009-12-31
RS58248B1 (sr) 2019-03-29
US20190192423A1 (en) 2019-06-27
WO2008149320A3 (fr) 2009-02-05
HRP20161785T1 (hr) 2017-03-10
PL2164467T3 (pl) 2017-07-31
ES2611020T3 (es) 2017-05-04
EP2500014A2 (fr) 2012-09-19
HUE031550T2 (en) 2017-07-28
SI2164467T1 (sl) 2017-05-31
IL202501A0 (en) 2010-06-30
LT2500014T (lt) 2019-01-25
ES2694401T3 (es) 2018-12-20
EP2500014A3 (fr) 2012-11-07
EP2500014B1 (fr) 2018-08-08
ME00959B (fr) 2012-06-20
KR20100023950A (ko) 2010-03-04
CO6251234A2 (es) 2011-02-21
LT2164467T (lt) 2017-01-25
EP2164467A2 (fr) 2010-03-24
CY1118434T1 (el) 2017-06-28
MY150450A (en) 2014-01-30
US10166181B2 (en) 2019-01-01
DK2500014T3 (en) 2018-12-03
NZ582423A (en) 2011-10-28

Similar Documents

Publication Publication Date Title
HK1216232A1 (zh) 控釋藥物組合物
HRP20181854T1 (hr) Farmaceutski pripravak sporog oslobađanja pripremljen od mikročestica
EP2308473A4 (fr) Composition pharmaceutique contenant des microparticules à revêtement de surface
EP2240173A4 (fr) Composition pharmaceutique de duloxétine à libération retardée
PT2251006T (pt) Micropartículas e suas composições farmacêuticas
AP3542A (en) Anti-malarial pharmaceutical composition
GB0902648D0 (en) Pharmaceutical compounds and compositions
EP2405754A4 (fr) Compositions pharmaceutiques à libération modifiée de buprénorphine
PL2277511T3 (pl) Kompozycje farmaceutyczne lewetiracetamu o przedłużonym uwalnianiu
IL178378A0 (en) Extended release pharmaceutical compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions